Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer;Apport d'un cocktail d'anticorps anti-(p63 + p504s) dans le diagnostic de cancer de prostate

Annales de Pathologie

Volumn 24, Issue 1, 2004, Pages 6-16

  Molinié, Vincent ^a   Hervé, Jean Marie ^b   Lebret, Thierry ^b   Lugagne Delpon, Pierre Marie ^b   Saporta, François ^b   Yonneau, Laurent ^b   Botto, Henry ^b   Baglin, Anne Catherine ^a  

^a Service de Pathologie

^b FOCH HOSPITAL   (France)

Author keywords

Alpha methylacyl CoA racemase; AMACR; ASAP; CK 5 6; Immunohistochemistry; p504s; p63; PIN; Prostate cancer

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CYTOKERATIN; CYTOKERATIN 5; CYTOKERATIN 6; MONOCLONAL ANTIBODY; PROTEIN P63; RACEMASE; UNCLASSIFIED DRUG;

ARTICLE; ATROPHY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE ADENOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 2542491076     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Molinié V. Néoplasie intra épithéliale prostatique. Diagnostic et conduite à tenir. Ann Pathol 2001; 21: 245-54.
2. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filaments proteins: II Distribution of filament protein in normal human tissues. Am J Pathol 1984; 114: 309-21.
3. Molinié V, Vieillefond A, Cochand-Priollet B, Dauge-Geffroy MC, Lefrère-Belda MA, De Fromont M et al. Recommandations pratiques pour les prélèvements prostatiques. Ann Pathol 1999; 19: 549-56.
4. Villers A, Rébillard X, Soulié M, Davin JL, Coloby P, Moreau JL et al. Dépistage du cancer de la prostate. Progrès Urol 2003; 13: 209-14.
5. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics. CA Cancer J Clin 1999; 8: 1999.
6. Valeri A, Cussenot O. Épidémiologie, géné tique, dépistage et prévention. In Cussenot O, Teillac P. Le cancer de la prostate. John Libbey Eds. 1999; p. 17-36.
7. Villers A, Molinié V. Indication et stratégie de nouvelles biopsies après diagnostic de néoplasie intra-épithé liale prostatique. Progrès Urol 2000; 10: 1267-70.
8. Zhou M, Shah R, Shen R, Rubin MA. Basal cell cocktail (34βE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol 2003; 27: 365-71.
9. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filaments proteins: II Distribution of filament protein in normal human tissues. Am J Pathol 1984; 114: 309-21.
10. Brawer MK, Peehl DM, Stamey TA, Bostwick DG. Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985; 45: 3663-7.
11. Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 1989; 13: 389-96.
12. Wojno KJ, Epstein JI. The utility of basal cell cell-specific anticytokeratin antibody (34 beta E 12) in the dignostis of prostate cancer: a review of 228 cases. Am J Surg Pathol 1995; 19: 251-60.
13. Shah RB, Zhou M, LeBlanc M, Synder M, Rubbin M. Comparaison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002; 26: 1161-8.
14. Helpap B, Kollermann J, Oehler U. Limiting the diagnosis of atypical small glandular proliférations in needle biopsies of the prostate by the use of immunohistochemistry. J Pathol 2001; 193: 350-3.
15. Iczkowski KA, Cheng L, Crawford BG, Bostwick DG. Steam heat with an EDTA buffer and protease digestion optimizes immunohistochemical expression of basal cell-specific antikeratin 34betaE12 to discriminate cancer in prostatic epithelium. Mod Pathol 1999; 12: 1-4.
16. Varma M, Linden MD, Amin MB. Effects of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of parostate tissues. Mod Pathol 1999; 12: 472-8.
17. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403-39.
18. Carella R, Deleonardi G, D'Errico A, Salerno A, Egarter-Vigl E, Seebacher C et al. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis. Am J Surg Pathol 2001; 25: 43-50.
19. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002; 161: 1991-6
20. Abrahams NA, Ormsby AH, Brainard J. Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology 2002; 41: 35-41.
21. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000; 157: 1769-75.
22. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A et al. P 504 S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001; 25: 1397-404.
23. Parsons JK, Gage WR, Nelson WG, De Marzo AM. p63 protein expression is rare in prostate adenocarcinoma: implication for cancer diagnosis and carcinogenesis. Urology 2001; 58: 619-24.
24. Zhou M, Chinnayaian AM, Kleer CG, Lucas PC, Rubin MA. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 2002; 26: 926-31.
25. Zheng SL, Chang BL, Faith DA, Johnson JR, Isaacs SD, Hawkins GA et al. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Research 2002; 52: 6485-8;
26. Amery L, Fransen M, De Nys K, Mannaerts GP, Van Veldhoven PP. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J Lipid Res 2000; 41: 1752-9.
27. Ferdinandusse S, Denis S, Clayton PT, Graham A, Rees JE, Allen JT et al. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 2000; 24: 188-91.
28. Schmitz W, Albers C, Fingerhut R, Conzelmann E. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur J Biochem 1995; 231: 815-22.
29. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barette TR et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287: 1662-70.
30. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennet CJ et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Research 2002; 62: 2220-6.
31. Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR et al. P504S/α-Methylacyl-CoA Racemase. A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 2002; 26: 1169-74.
32. Beach R, Gown M, de Peralta-Venturina MN, Folpe AL, Yaziji H, Salles PG et al. P 504s immunohistochemical detection in 405 prostatic specimens including 376 18-Gauge needle biopsies. Am J Surg Pathol 2002; 26: 1588-96.
33. Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR et al. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 2002; 25: 921-5.